[ad_1]
Synopsis
Dr Lal PathLabs (LPL), India’s largest diagnostics participant by income and presence, is slated to turn into larger with the acquisition of Suburban Diagnostics, which has a large presence in western India. On the complete deal worth of Rs 1,150 crore, LPL valued Sequoia Capital-backed Suburban at practically 4 instances its FY21 income.
ET Intelligence Group: Dr Lal PathLabs (LPL), India’s largest diagnostics participant by income and presence, is slated to turn into larger with the acquisition of Suburban Diagnostics, which has a large presence in western India. On the complete deal worth of Rs 1,150 crore, LPL valued Sequoia Capital-backed Suburban at practically 4 instances its FY21 income.
The acquisition goes to offer LPL scale and penetration – it is going to assist it add 44
- FONT SIZE
AbcSmall
AbcMedium
AbcMassive
Register to learn the total article
You’ve bought this Prime Story as a Free Reward
₹399/month
Month-to-month
PLAN
Billed Quantity ₹399
₹208/month
(Save 49%)
Yearly
PLAN
Billed Quantity ₹2,499
15
Days Trial
+Contains DocuBay and TimesPrime Membership.
₹150/month
(Save 63%)
2-12 months
PLAN
Billed Quantity ₹3,599
15
Days Trial
+Contains DocuBay and TimesPrime Membership.
Already a Member? Signal In now
Get Supply
Why ?
-
Unique Financial Occasions Tales, Editorials & Professional opinion throughout 20+ sectors
-
Inventory evaluation. Market Analysis. Business Developments on 4000+ Shares
-
Clear expertise with
Minimal Advertisements -
Remark & Interact with ET Prime neighborhood -
Unique invitations to Digital Occasions with Business Leaders -
A trusted staff of Journalists & Analysts who can finest filter sign from noise
[ad_2]
Source link